Henrik Gronfeldt-Sorensen, Director at Enochian Biosciences Inc (ENOB), bought 50,000 shares at $2.00 ($100K) on 2019-01-10, disclosed to the SEC on 2019-01-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.